{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:47:27Z","timestamp":1787510847169,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS105709"],"award-info":[{"award-number":["R01NS105709"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS091161"],"award-info":[{"award-number":["R01NS091161"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS079651"],"award-info":[{"award-number":["R01NS079651"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s10038-019-0639-8","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T09:49:04Z","timestamp":1562838544000},"page":"995-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Full sequence of mutant huntingtin 3\u2032-untranslated region and modulation of its gene regulatory activity by endogenous microRNA"],"prefix":"10.1038","volume":"64","author":[{"given":"Kyung-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawther","family":"Abu Elneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Wan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Whan","family":"Keum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-5731","authenticated-orcid":false,"given":"David","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Gusella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihn Sik","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-0787","authenticated-orcid":false,"given":"Jong-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"639_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"THDCRG.","year":"1993","unstructured":"THDCRG. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 1993;72:971\u201383.","journal-title":"Cell"},{"key":"639_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","volume":"98","author":"JW Keum","year":"2016","unstructured":"Keum JW, Shin A, Gillis T, Mysore JS, Abu Elneel K, Lucente D, et al. The HTT CAG-expansion mutation determines age at death but not disease duration in Huntington disease. Am J Hum Genet 2016;98:287\u201398.","journal-title":"Am J Hum Genet"},{"key":"639_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 2012;78:690\u20135.","journal-title":"Neurology"},{"key":"639_CR4","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","volume":"25","author":"MS Keiser","year":"2016","unstructured":"Keiser MS, Kordasiewicz HB, McBride JL. Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington\u2019s disease and spinocerebellar ataxia. Hum Mol Genet 2016;25:R53\u201364.","journal-title":"Hum Mol Genet"},{"key":"639_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","volume":"16","author":"EJ Wild","year":"2017","unstructured":"Wild EJ, Tabrizi SJ. Therapies targeting DNA and RNA in Huntington\u2019s disease. Lancet Neurol 2017;16:837\u201347.","journal-title":"Lancet Neurol"},{"key":"639_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","volume":"150","author":"D Yu","year":"2012","unstructured":"Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, et al. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell 2012;150:895\u2013908.","journal-title":"Cell"},{"key":"639_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuron.2005.11.008","volume":"48","author":"NM Bonini","year":"2005","unstructured":"Bonini NM, La Spada AR. Silencing polyglutamine degeneration with RNAi. Neuron 2005;48:715\u20138.","journal-title":"Neuron"},{"key":"639_CR8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/ejhg.2013.2","volume":"21","author":"FK Baine","year":"2013","unstructured":"Baine FK, Kay C, Ketelaar ME, Collins JA, Semaka A, Doty CN, et al. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. Eur J Hum Genet: Ejhg 2013;21:1120\u20137.","journal-title":"Eur J Hum Genet: Ejhg"},{"key":"639_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ejhg.2017.125","volume":"25","author":"MJ Chao","year":"2017","unstructured":"Chao MJ, Gillis T, Atwal RS, Mysore JS, Arjomand J, Harold D, et al. Haplotype-based stratification of Huntington\u2019s disease. Eur J Hum Genet: Ejhg 2017;25:1202\u20139.","journal-title":"Eur J Hum Genet: Ejhg"},{"key":"639_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","volume":"84","author":"SC Warby","year":"2009","unstructured":"Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009;84:351\u201366.","journal-title":"Am J Hum Genet"},{"key":"639_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ng1093-174","volume":"5","author":"YP Goldberg","year":"1993","unstructured":"Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, Squitieri F, et al. Molecular analysis of new mutations for Huntington\u2019s disease: intermediate alleles and sex of origin effects. Nat Genet 1993;5:174\u20139.","journal-title":"Nat Genet"},{"key":"639_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ajhg.2015.07.017","volume":"97","author":"JM Lee","year":"2015","unstructured":"Lee JM, Kim KH, Shin A, Chao MJ, Abu Elneel K, Gillis T, et al. Sequence-level analysis of the major European Huntington disease haplotype. Am J Hum Genet 2015;97:435\u201344.","journal-title":"Am J Hum Genet"},{"key":"639_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1093-168","volume":"5","author":"RH Myers","year":"1993","unstructured":"Myers RH, MacDonald ME, Koroshetz WJ, Duyao MP, Ambrose CM, Taylor SA, et al. De novo expansion of a (CAG)n repeat in sporadic Huntington\u2019s disease. Nat Genet 1993;5:168\u201373.","journal-title":"Nat Genet"},{"key":"639_CR14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ajmg.b.30970","volume":"153B","author":"A Semaka","year":"2010","unstructured":"Semaka A, Collins JA, Hayden MR. Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles). Am J Med Genet Part B, Neuropsychiatr Genet 2010;153B:314\u201320.","journal-title":"Am J Med Genet Part B, Neuropsychiatr Genet"},{"key":"639_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejmg.2014.11.005","volume":"58","author":"A Semaka","year":"2015","unstructured":"Semaka A, Kay C, Belfroid RD, Bijlsma EK, Losekoot M, van Langen IM, et al. A new mutation for Huntington disease following maternal transmission of an intermediate allele. Eur J Med Genet 2015;58:28\u201330.","journal-title":"Eur J Med Genet"},{"key":"639_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ajhg.2012.01.005","volume":"90","author":"JM Lee","year":"2012","unstructured":"Lee JM, Gillis T, Mysore JS, Ramos EM, Myers RH, Hayden MR, et al. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet 2012;90:434\u201344.","journal-title":"Am J Hum Genet"},{"key":"639_CR17","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Warby SC, Southwell AL, Doty CN, Greenlee S, Skotte N, et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin. Mol Ther J Am Soc Gene Ther 2011;19:2178\u201385.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"461","key":"639_CR18","doi-asserted-by":"publisher","first-page":"eaar3959","DOI":"10.1126\/scitranslmed.aar3959","volume":"10","author":"Amber L. Southwell","year":"2018","unstructured":"Southwell AL, Kordasiewicz HB, Langbehn D, Skotte NH, Parsons MP, Villanueva EB, et al. Huntingtin suppression restores cognitive function in a mouse model of Huntington\u2019s disease. Sci Transl Med. 2018;10. pii: 10\/461\/eaar3959. https:\/\/doi.org\/10.1126\/scitranslmed.aar3959 .","journal-title":"Science Translational Medicine"},{"key":"639_CR19","first-page":"4566","volume":"25","author":"JW Shin","year":"2016","unstructured":"Shin JW, Kim KH, Chao MJ, Atwal RS, Gillis T, MacDonald ME, et al. Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9. Hum Mol Genet 2016;25:4566\u201376.","journal-title":"Hum Mol Genet"},{"key":"639_CR20","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, et al. RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA 2005;102:5820\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"639_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, et al. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther J Am Soc Gene Ther 2009;17:1053\u201363.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"639_CR22","doi-asserted-by":"publisher","first-page":"e1004188","DOI":"10.1371\/journal.pgen.1004188","volume":"10","author":"AG Hoss","year":"2014","unstructured":"Hoss AG, Kartha VK, Dong X, Latourelle JC, Dumitriu A, Hadzi TC, et al. MicroRNAs located in the Hox gene clusters are implicated in huntington\u2019s disease pathogenesis. PLoS Genet 2014;10:e1004188.","journal-title":"PLoS Genet"},{"key":"639_CR23","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Marti","year":"2010","unstructured":"Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, Porta S, et al. A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic acids Res 2010;38:7219\u201335.","journal-title":"Nucleic acids Res"},{"key":"639_CR24","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. The. J Neurosci 2008;28:14341\u20136.","journal-title":"J Neurosci"},{"key":"639_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.4161\/rna.8.6.16035","volume":"8","author":"M Sinha","year":"2011","unstructured":"Sinha M, Ghose J, Bhattarcharyya NP. Micro RNA -214,-150,-146a and-125b target Huntingtin gene. RNA Biol 2011;8:1005\u201321.","journal-title":"RNA Biol"},{"key":"639_CR26","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000004844","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, et al. MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology 2018;90:e264\u201372.","journal-title":"Neurology"},{"key":"639_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02257483","volume":"20","author":"CM Ambrose","year":"1994","unstructured":"Ambrose CM, Duyao MP, Barnes G, Bates GP, Lin CS, Srinidhi J, et al. Structure and expression of the Huntington\u2019s disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat cell Mol Genet 1994;20:27\u201338.","journal-title":"Somat cell Mol Genet"},{"key":"639_CR28","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/hmg\/2.10.1541","volume":"2","author":"B Lin","year":"1993","unstructured":"Lin B, Rommens JM, Graham RK, Kalchman M, MacDonald H, Nasir J, et al. Differential 3\u2032 polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. Hum Mol Genet 1993;2:1541\u20135.","journal-title":"Hum Mol Genet"},{"key":"639_CR29","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1016\/j.celrep.2017.09.009","volume":"20","author":"L Romo","year":"2017","unstructured":"Romo L, Ashar-Patel A, Pfister E, Aronin N. Alterations in mRNA 3\u2032 UTR isoform abundance accompany gene expression changes in human Huntington\u2019s disease brains. Cell Rep. 2017;20:3057\u201370.","journal-title":"Cell Rep"},{"key":"639_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008;455:58\u201363.","journal-title":"Nature"},{"key":"639_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008;455:64\u201371.","journal-title":"Nature"},{"key":"639_CR32","doi-asserted-by":"publisher","first-page":"Suppl:S14","DOI":"10.1038\/ng1799","volume":"38","author":"J Krutzfeldt","year":"2006","unstructured":"Krutzfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet 2006;38(Suppl):S14\u20139.","journal-title":"Nat Genet"},{"key":"639_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495\u2013500.","journal-title":"Nat Genet"},{"key":"639_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003;115:787\u201398.","journal-title":"Cell"},{"key":"639_CR35","doi-asserted-by":"publisher","first-page":"e0137637","DOI":"10.1371\/journal.pone.0137637","volume":"10","author":"MH Fu","year":"2015","unstructured":"Fu MH, Li CL, Lin HL, Tsai SJ, Lai YY, Chang YF, et al. The potential regulatory mechanisms of miR-196a in Huntington\u2019s disease through bioinformatic analyses. PloS ONE 2015;10:e0137637.","journal-title":"PloS one"},{"key":"639_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"J Kocerha","year":"2014","unstructured":"Kocerha J, Xu Y, Prucha MS, Zhao D, Chan AW. microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys. Mol brain. 2014;7:46.","journal-title":"Mol brain"},{"key":"639_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12017-012-8183-0","volume":"14","author":"M Sinha","year":"2012","unstructured":"Sinha M, Mukhopadhyay S, Bhattacharyya NP. Mechanism(s) of alteration of micro RNA expressions in Huntington\u2019s disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease. Neuromolecular Med. 2012;14:221\u201343.","journal-title":"Neuromolecular Med"},{"key":"639_CR38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00018-015-2093-x","volume":"73","author":"I Basak","year":"2016","unstructured":"Basak I, Patil KS, Alves G, Larsen JP, Moller SG. microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases. Cell Mol life Sci. 2016;73:811\u201327.","journal-title":"Cell Mol life Sci"},{"key":"639_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-015-0083-3","volume":"8","author":"AG Hoss","year":"2015","unstructured":"Hoss AG, Labadorf A, Latourelle JC, Kartha VK, Hadzi TC, Gusella JF, et al. miR-10b-5p expression in Huntington\u2019s disease brain relates to age of onset and the extent of striatal involvement. BMC Med Genom. 2015;8:10.","journal-title":"BMC Med Genom"},{"key":"639_CR40","doi-asserted-by":"publisher","first-page":"16999","DOI":"10.3390\/ijms140816999","volume":"14","author":"E Kozlowska","year":"2013","unstructured":"Kozlowska E, Krzyzosiak WJ, Koscianska E. Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs. Int J Mol Sci. 2013;14:16999\u20137016.","journal-title":"Int J Mol Sci"},{"key":"639_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bbrc.2017.05.040","volume":"488","author":"JJ Ban","year":"2017","unstructured":"Ban JJ, Chung JY, Lee M, Im W, Kim M. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington\u2019s disease. Biochem Biophys Res Commun. 2017;488:316\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"639_CR42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","volume":"93","author":"PH Cheng","year":"2013","unstructured":"Cheng PH, Li CL, Chang YF, Tsai SJ, Lai YY, Chan AW, et al. miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models. Am J Hum Genet 2013;93:306\u201312.","journal-title":"Am J Hum Genet"},{"key":"639_CR43","doi-asserted-by":"publisher","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PloS ONE 2013;8:e54222.","journal-title":"PloS one"},{"key":"639_CR44","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834\u20138.","journal-title":"Nature"},{"key":"639_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer cell 2010;18:11\u201322.","journal-title":"Cancer cell"},{"key":"639_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"R Johnson","year":"2009","unstructured":"Johnson R, Buckley NJ. Gene dysregulation in Huntington\u2019s disease: REST, microRNAs and beyond. Neuromolecular Med 2009;11:183\u201399.","journal-title":"Neuromolecular Med"},{"key":"639_CR47","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.jmb.2013.03.007","volume":"425","author":"AM Gurtan","year":"2013","unstructured":"Gurtan AM, Sharp PA. The role of miRNAs in regulating gene expression networks. J Mol Biol. 2013;425:3582\u2013600.","journal-title":"J Mol Biol"},{"key":"639_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215\u201333.","journal-title":"Cell"},{"key":"639_CR49","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1371\/journal.pcbi.0010013","volume":"1","author":"D Grun","year":"2005","unstructured":"Grun D, Wang YL, Langenberger D, Gunsalus KC, Rajewsky N. microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol. 2005;1:e13.","journal-title":"PLoS Comput Biol"},{"key":"639_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15\u201320.","journal-title":"Cell"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0639-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0639-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0639-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T17:46:52Z","timestamp":1721497612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-019-0639-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1038\/s10038-019-0639-8","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"29 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}